HSD17B13-IN-9 (252) is a 17beta-Hydroxysteroid dehydrogenases (HSD17B13) inhibitor, with an IC50 of 0.01 µM for 50 nM HSD17B13. Used in NAFLD (Nonalcoholic fatty liver diseases) research[1].
Molecular Weight:
430.44
Purity:
99.92
CAS Number:
[2576690-78-1]
Formula:
C22H17F3N2O2S
Target:
17beta-HSD
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted